Indian society for study of pain, cancer pain special interest group guidelines on pharmacological management of cancer pain (Part I)

Raghavendra Ramanjulu, Raghu S Thota, Arif Ahmed, Parmanand Jain, Naveen Salins, Sushma Bhatnagar, Aparna Chatterjee, Dipasri BhattacharyaIndian Journal of Palliative Care 2020 26(2):173-179 The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain in adults provides a structured, step-wise approach which will help to improve the management of cancer pain and to provide the patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub drafts addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website, and circulated by E-mail to all the ISSP and Indian Association of Palliative Care (IAPC) members. We recommend that analgesics for cancer pain management should follow the World Health Organization three-step analgesic ladder appropriate for the severity of pain. The use of paracetamol and nonsteroidal anti-inflammatory drugs alone or in combination with opioids for mild-to-moderate pain should be used. For mild-to-moderate pain, weak opioids such as tramadol, tapentadol, and codeine can be given in combination with nonopioid analgesics. We recommend morphine as the opioid of first choice for moderate-to-severe cancer pain.
Source: Indian Journal of Palliative Care - Category: Palliative Care Authors: Source Type: research